TR200201036T2 - İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri - Google Patents

İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri

Info

Publication number
TR200201036T2
TR200201036T2 TR2002/01036T TR200201036T TR200201036T2 TR 200201036 T2 TR200201036 T2 TR 200201036T2 TR 2002/01036 T TR2002/01036 T TR 2002/01036T TR 200201036 T TR200201036 T TR 200201036T TR 200201036 T2 TR200201036 T2 TR 200201036T2
Authority
TR
Turkey
Prior art keywords
amino acids
peptido
immunotherapy
mimics
formula
Prior art date
Application number
TR2002/01036T
Other languages
English (en)
Inventor
Joanna Van Staveren Catherina
Marius Timmers Cornelis
Johannes Marie Galen Van Philippus
Marcellus Alphonsus Knegtel Rnaldus
Maria Helena Boots Anna
Martinus Maria Miltenburg Andreas
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200201036T2 publication Critical patent/TR200201036T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Bu bulus H-Arg-Ser-Phe-Thr-Leu-Ala-Ser-Glu-Thr-Val-Gly-OH'dan türetilen Q-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-Z(formül II) genel formülünü haiz bir degistirilmis peptite iliskindir.(II) genel formülünde A1 ila A13, (I) formülündeki amino asitlere karsilik gelir; Q, H'ya karsilik gelir ve Z, OH'yakarsilik gelir. Bulusa uygun degisiklikler, asagidakilerden seçilir:a)A1 ila A13'te 1-6, tercihen 1-4 amino asidin dogal olmayan amino asitler veya amino asitler ile yer degistirmesi; b) bir veya birden fazla amit baginin indirgenmis amit baglari veya etilen izosterler ile yer degistirmesi; c) Q ve/veya Z'de yer degistirmeler ve istege bagli olarak d) toplam 6 degisiklige kadar dogal amino asitlerin yer degistirmesi.
TR2002/01036T 1999-10-18 2000-10-12 İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri TR200201036T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203427 1999-10-18

Publications (1)

Publication Number Publication Date
TR200201036T2 true TR200201036T2 (tr) 2002-08-21

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01036T TR200201036T2 (tr) 1999-10-18 2000-10-12 İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri

Country Status (23)

Country Link
EP (1) EP1226167A1 (tr)
JP (1) JP2003512388A (tr)
KR (1) KR20020047245A (tr)
CN (1) CN1379786A (tr)
AR (1) AR026068A1 (tr)
AU (1) AU780238B2 (tr)
BR (1) BR0014803A (tr)
CA (1) CA2386398A1 (tr)
CO (1) CO5271650A1 (tr)
CZ (1) CZ20021356A3 (tr)
HK (1) HK1046693A1 (tr)
HU (1) HUP0203504A3 (tr)
IL (1) IL148778A0 (tr)
MX (1) MXPA02003520A (tr)
NO (1) NO20021763D0 (tr)
NZ (1) NZ518256A (tr)
PE (1) PE20010692A1 (tr)
PL (1) PL354590A1 (tr)
RU (1) RU2002113107A (tr)
SK (1) SK6842002A3 (tr)
TR (1) TR200201036T2 (tr)
WO (1) WO2001029081A1 (tr)
ZA (1) ZA200202577B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
US20100240137A1 (en) * 2006-04-06 2010-09-23 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
EP2114462B1 (en) * 2006-12-21 2013-06-05 Universite De Geneve Compounds for fluorescence imaging
AU2009207922B2 (en) 2008-01-23 2015-05-14 Herlev Hospital YKL-40 as a general marker for non-specific disease
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
EP3215172B1 (en) * 2014-11-07 2023-04-26 Kineta Chronic Pain, Llc. Modifications and uses of conotoxin peptides
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
WO1997046578A1 (en) * 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

Also Published As

Publication number Publication date
RU2002113107A (ru) 2004-01-10
CN1379786A (zh) 2002-11-13
EP1226167A1 (en) 2002-07-31
WO2001029081A1 (en) 2001-04-26
CO5271650A1 (es) 2003-04-30
HUP0203504A2 (hu) 2003-04-28
ZA200202577B (en) 2003-09-23
HK1046693A1 (zh) 2003-01-24
NZ518256A (en) 2004-01-30
CA2386398A1 (en) 2001-04-26
NO20021763L (no) 2002-04-15
AR026068A1 (es) 2002-12-26
IL148778A0 (en) 2002-09-12
SK6842002A3 (en) 2002-09-10
MXPA02003520A (es) 2002-08-20
HUP0203504A3 (en) 2005-03-29
CZ20021356A3 (cs) 2002-07-17
JP2003512388A (ja) 2003-04-02
PE20010692A1 (es) 2001-07-06
BR0014803A (pt) 2002-06-11
AU780238B2 (en) 2005-03-10
NO20021763D0 (no) 2002-04-15
KR20020047245A (ko) 2002-06-21
AU1139601A (en) 2001-04-30
PL354590A1 (en) 2004-01-26

Similar Documents

Publication Publication Date Title
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
TR199902997T2 (tr) "LH-RH peptit analoglari, bunlarin kullanimlari ve bunlari içeren farmasötik terkipler"
CY1109978T1 (el) Αντιγονικα πεπτιδια εξαγομενα απο τελομεραση
TR200402703T4 (tr) Çözünür CTLA4 mutantları ve bunların kullanımı.
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
PT2360176E (pt) Expressão híbrida e em série de proteínas derivadas de neisseria
TR199801845T2 (tr) Dimerik fibroblast aktiflestirici protein alfa ve kullanimlari.
TR200201036T2 (tr) İmmünoterapide kullanmak için değiştirilmiş peptitler ve peptido-taklitleri
ATE495247T1 (de) Chromoprotein und fluoroproteine
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
ATE102217T1 (de) Synthetisches peptid fuer einen hiv-1 impfstoff.
DK1012175T3 (da) Peptid med affinitet til koagulationsfaktor VIII
AP2002002584A0 (en) Protease Inhibitors And Thier Pharmaceutical Uses.
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
MX9303963A (es) Suministro dirigido de factores de desarrollo para regeneracion de hueso.
AU2003216025A1 (en) Novel polypeptide scaffolds and use thereof
ATE315577T1 (de) Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen
WO1992006199A3 (fr) Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.
JO1999B1 (en) Isotopes of the hormone 'LH-RH' have their uses and the chemical compounds they contain
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
ES2167464T3 (es) Procedimiento para la preparacion de n-carboxianhidridos de aminoacidos a partir de n-(n'-nitrosocarbamoil)aminoacidos.
TR199901831T2 (tr) Kollagen-II'ye özgü bir T-hücresi epitopundan olusan peptitler.
TR200103042T2 (tr) N”rotrofin g‡lendiricileri